nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—Dissociation—Varenicline—nicotine dependence	0.0942	0.216	CcSEcCtD
Disopyramide—ORM1—saliva—nicotine dependence	0.0617	0.261	CbGeAlD
Disopyramide—Rash generalised—Varenicline—nicotine dependence	0.0322	0.0738	CcSEcCtD
Disopyramide—KCND2—cardiovascular system—nicotine dependence	0.026	0.11	CbGeAlD
Disopyramide—KCND3—cardiovascular system—nicotine dependence	0.0227	0.0962	CbGeAlD
Disopyramide—KCND2—midbrain—nicotine dependence	0.0203	0.0862	CbGeAlD
Disopyramide—KCND3—midbrain—nicotine dependence	0.0177	0.0751	CbGeAlD
Disopyramide—Mydriasis—Varenicline—nicotine dependence	0.0171	0.0393	CcSEcCtD
Disopyramide—SCN5A—cardiovascular system—nicotine dependence	0.0136	0.0577	CbGeAlD
Disopyramide—KCND2—brain—nicotine dependence	0.0128	0.0541	CbGeAlD
Disopyramide—Dry eye—Varenicline—nicotine dependence	0.0126	0.029	CcSEcCtD
Disopyramide—CHRM2—cardiovascular system—nicotine dependence	0.0116	0.0492	CbGeAlD
Disopyramide—KCND3—Neuronal System—CHRNB3—nicotine dependence	0.0114	0.0399	CbGpPWpGaD
Disopyramide—KCND3—brain—nicotine dependence	0.0111	0.0472	CbGeAlD
Disopyramide—KCND3—Neuronal System—CHRNA6—nicotine dependence	0.0108	0.0378	CbGpPWpGaD
Disopyramide—CHRM1—cardiovascular system—nicotine dependence	0.0106	0.0447	CbGeAlD
Disopyramide—Hypoglycaemia—Varenicline—nicotine dependence	0.0102	0.0233	CcSEcCtD
Disopyramide—KCND2—Neuronal System—CHRNB3—nicotine dependence	0.0102	0.0355	CbGpPWpGaD
Disopyramide—Psychotic disorder—Varenicline—nicotine dependence	0.00969	0.0222	CcSEcCtD
Disopyramide—KCND2—Neuronal System—CHRNA6—nicotine dependence	0.00963	0.0337	CbGpPWpGaD
Disopyramide—Levomethadyl Acetate—CHRNB4—nicotine dependence	0.00958	0.228	CrCbGaD
Disopyramide—Urinary retention—Varenicline—nicotine dependence	0.00944	0.0216	CcSEcCtD
Disopyramide—Abdominal pain upper—Varenicline—nicotine dependence	0.00906	0.0208	CcSEcCtD
Disopyramide—Hypokalaemia—Varenicline—nicotine dependence	0.00903	0.0207	CcSEcCtD
Disopyramide—Methadyl Acetate—OPRM1—nicotine dependence	0.00867	0.207	CrCbGaD
Disopyramide—Abdominal distension—Varenicline—nicotine dependence	0.00863	0.0198	CcSEcCtD
Disopyramide—Pollakiuria—Varenicline—nicotine dependence	0.00792	0.0182	CcSEcCtD
Disopyramide—Erectile dysfunction—Varenicline—nicotine dependence	0.0079	0.0181	CcSEcCtD
Disopyramide—KCND3—Neuronal System—GABRA4—nicotine dependence	0.00782	0.0273	CbGpPWpGaD
Disopyramide—Methadone—CHRNA10—nicotine dependence	0.00781	0.186	CrCbGaD
Disopyramide—Weight increased—Varenicline—nicotine dependence	0.00781	0.0179	CcSEcCtD
Disopyramide—Depression—Varenicline—nicotine dependence	0.00763	0.0175	CcSEcCtD
Disopyramide—KCND3—Neuronal System—CHRNB4—nicotine dependence	0.00749	0.0262	CbGpPWpGaD
Disopyramide—Bradycardia—Varenicline—nicotine dependence	0.00699	0.016	CcSEcCtD
Disopyramide—KCND2—Neuronal System—GABRA4—nicotine dependence	0.00697	0.0243	CbGpPWpGaD
Disopyramide—KCND3—Neuronal System—CHRNA5—nicotine dependence	0.00697	0.0243	CbGpPWpGaD
Disopyramide—Hypoaesthesia—Varenicline—nicotine dependence	0.00683	0.0157	CcSEcCtD
Disopyramide—SCN5A—brain—nicotine dependence	0.00669	0.0283	CbGeAlD
Disopyramide—KCND2—Neuronal System—CHRNB4—nicotine dependence	0.00668	0.0233	CbGpPWpGaD
Disopyramide—Levomethadyl Acetate—CHRNA3—nicotine dependence	0.00664	0.158	CrCbGaD
Disopyramide—KCND2—Neuronal System—CHRNA5—nicotine dependence	0.00621	0.0217	CbGpPWpGaD
Disopyramide—Arrhythmia—Varenicline—nicotine dependence	0.00613	0.0141	CcSEcCtD
Disopyramide—Flatulence—Varenicline—nicotine dependence	0.00589	0.0135	CcSEcCtD
Disopyramide—Dysgeusia—Varenicline—nicotine dependence	0.00585	0.0134	CcSEcCtD
Disopyramide—KCND2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00579	0.0202	CbGpPWpGaD
Disopyramide—CHRM2—brain—nicotine dependence	0.00569	0.0241	CbGeAlD
Disopyramide—KCND3—Neuronal System—CHRNA3—nicotine dependence	0.00568	0.0198	CbGpPWpGaD
Disopyramide—Vision blurred—Varenicline—nicotine dependence	0.00563	0.0129	CcSEcCtD
Disopyramide—SLC22A1—brain—nicotine dependence	0.00559	0.0237	CbGeAlD
Disopyramide—Ill-defined disorder—Varenicline—nicotine dependence	0.00554	0.0127	CcSEcCtD
Disopyramide—Angioedema—Varenicline—nicotine dependence	0.00546	0.0125	CcSEcCtD
Disopyramide—Malaise—Varenicline—nicotine dependence	0.00539	0.0124	CcSEcCtD
Disopyramide—Vertigo—Varenicline—nicotine dependence	0.00537	0.0123	CcSEcCtD
Disopyramide—Syncope—Varenicline—nicotine dependence	0.00536	0.0123	CcSEcCtD
Disopyramide—Loss of consciousness—Varenicline—nicotine dependence	0.00525	0.012	CcSEcCtD
Disopyramide—CHRM1—brain—nicotine dependence	0.00518	0.022	CbGeAlD
Disopyramide—Chest pain—Varenicline—nicotine dependence	0.00509	0.0117	CcSEcCtD
Disopyramide—KCND2—Neuronal System—CHRNA3—nicotine dependence	0.00506	0.0177	CbGpPWpGaD
Disopyramide—Discomfort—Varenicline—nicotine dependence	0.00503	0.0115	CcSEcCtD
Disopyramide—KCND3—Neuronal System—CHRNB2—nicotine dependence	0.005	0.0175	CbGpPWpGaD
Disopyramide—Dry mouth—Varenicline—nicotine dependence	0.00498	0.0114	CcSEcCtD
Disopyramide—Oedema—Varenicline—nicotine dependence	0.00488	0.0112	CcSEcCtD
Disopyramide—Shock—Varenicline—nicotine dependence	0.0048	0.011	CcSEcCtD
Disopyramide—Thrombocytopenia—Varenicline—nicotine dependence	0.00478	0.011	CcSEcCtD
Disopyramide—Skin disorder—Varenicline—nicotine dependence	0.00474	0.0109	CcSEcCtD
Disopyramide—Hyperhidrosis—Varenicline—nicotine dependence	0.00472	0.0108	CcSEcCtD
Disopyramide—Anorexia—Varenicline—nicotine dependence	0.00465	0.0107	CcSEcCtD
Disopyramide—CHRM3—brain—nicotine dependence	0.00464	0.0196	CbGeAlD
Disopyramide—Hypotension—Varenicline—nicotine dependence	0.00456	0.0105	CcSEcCtD
Disopyramide—KCND3—Neuronal System—CHRNA4—nicotine dependence	0.00454	0.0159	CbGpPWpGaD
Disopyramide—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00446	0.0156	CbGpPWpGaD
Disopyramide—KCND2—Neuronal System—CHRNB2—nicotine dependence	0.00446	0.0156	CbGpPWpGaD
Disopyramide—Insomnia—Varenicline—nicotine dependence	0.00441	0.0101	CcSEcCtD
Disopyramide—Dyspnoea—Varenicline—nicotine dependence	0.00435	0.00997	CcSEcCtD
Disopyramide—Somnolence—Varenicline—nicotine dependence	0.00434	0.00995	CcSEcCtD
Disopyramide—Dyspepsia—Varenicline—nicotine dependence	0.00429	0.00985	CcSEcCtD
Disopyramide—KCND2—Circadian rythm related genes—DRD2—nicotine dependence	0.00428	0.015	CbGpPWpGaD
Disopyramide—Decreased appetite—Varenicline—nicotine dependence	0.00424	0.00972	CcSEcCtD
Disopyramide—Fatigue—Varenicline—nicotine dependence	0.00421	0.00964	CcSEcCtD
Disopyramide—Pain—Varenicline—nicotine dependence	0.00417	0.00957	CcSEcCtD
Disopyramide—Constipation—Varenicline—nicotine dependence	0.00417	0.00957	CcSEcCtD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00406	0.0142	CbGpPWpGaD
Disopyramide—KCND2—Neuronal System—CHRNA4—nicotine dependence	0.00405	0.0141	CbGpPWpGaD
Disopyramide—Feeling abnormal—Varenicline—nicotine dependence	0.00402	0.00922	CcSEcCtD
Disopyramide—Urticaria—Varenicline—nicotine dependence	0.00387	0.00889	CcSEcCtD
Disopyramide—Body temperature increased—Varenicline—nicotine dependence	0.00386	0.00884	CcSEcCtD
Disopyramide—Levomethadyl Acetate—OPRM1—nicotine dependence	0.00378	0.09	CrCbGaD
Disopyramide—CHRM1—Monoamine GPCRs—DRD2—nicotine dependence	0.00363	0.0127	CbGpPWpGaD
Disopyramide—CHRM3—Monoamine GPCRs—DRD2—nicotine dependence	0.00361	0.0126	CbGpPWpGaD
Disopyramide—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.00358	0.0125	CbGpPWpGaD
Disopyramide—Asthenia—Varenicline—nicotine dependence	0.0035	0.00803	CcSEcCtD
Disopyramide—Pruritus—Varenicline—nicotine dependence	0.00345	0.00791	CcSEcCtD
Disopyramide—Diarrhoea—Varenicline—nicotine dependence	0.00334	0.00765	CcSEcCtD
Disopyramide—Dextropropoxyphene—OPRM1—nicotine dependence	0.00326	0.0778	CrCbGaD
Disopyramide—Dizziness—Varenicline—nicotine dependence	0.00323	0.0074	CcSEcCtD
Disopyramide—Vomiting—Varenicline—nicotine dependence	0.0031	0.00711	CcSEcCtD
Disopyramide—Rash—Varenicline—nicotine dependence	0.00308	0.00705	CcSEcCtD
Disopyramide—Dermatitis—Varenicline—nicotine dependence	0.00307	0.00705	CcSEcCtD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00306	0.0107	CbGpPWpGaD
Disopyramide—Headache—Varenicline—nicotine dependence	0.00306	0.00701	CcSEcCtD
Disopyramide—CHRM1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00305	0.0107	CbGpPWpGaD
Disopyramide—CHRM3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00304	0.0106	CbGpPWpGaD
Disopyramide—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00301	0.0105	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0029	0.0102	CbGpPWpGaD
Disopyramide—Nausea—Varenicline—nicotine dependence	0.0029	0.00664	CcSEcCtD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00286	0.00998	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.0028	0.00977	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00279	0.00974	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00276	0.00964	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00271	0.00947	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00271	0.00946	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00246	0.0086	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00244	0.00854	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—CHRNB3—nicotine dependence	0.00235	0.00821	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—CHRNA6—nicotine dependence	0.00223	0.00778	CbGpPWpGaD
Disopyramide—Methadone—OPRM1—nicotine dependence	0.00221	0.0528	CrCbGaD
Disopyramide—SLC22A1—Neuronal System—CHRNB3—nicotine dependence	0.00219	0.00765	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.0021	0.00734	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00209	0.00732	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—CHRNA6—nicotine dependence	0.00207	0.00725	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00201	0.00704	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00196	0.00684	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00188	0.00656	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00187	0.00654	CbGpPWpGaD
Disopyramide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00185	0.00647	CbGpPWpGaD
Disopyramide—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00183	0.00639	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00174	0.0061	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00174	0.00608	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00173	0.00606	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00172	0.006	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00167	0.00583	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00166	0.00581	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00165	0.00575	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—GABRA4—nicotine dependence	0.00161	0.00562	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—CHRNB4—nicotine dependence	0.00154	0.00539	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00153	0.00533	CbGpPWpGaD
Disopyramide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0015	0.00525	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—GABRA4—nicotine dependence	0.0015	0.00524	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.0015	0.00524	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00149	0.00522	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00148	0.00517	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—CHRNB4—nicotine dependence	0.00144	0.00503	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—CHRNA5—nicotine dependence	0.00143	0.00501	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00142	0.00497	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.0014	0.00488	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00134	0.0047	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—CHRNA5—nicotine dependence	0.00134	0.00467	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00127	0.00443	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00125	0.00438	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00122	0.00426	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—CHRNA3—nicotine dependence	0.00117	0.00409	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00116	0.00404	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00114	0.00397	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—CHRNA3—nicotine dependence	0.00109	0.00381	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00103	0.0036	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—CHRNB2—nicotine dependence	0.00103	0.0036	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000968	0.00338	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000965	0.00337	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—CHRNB2—nicotine dependence	0.000959	0.00335	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000955	0.00334	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—CHRNA4—nicotine dependence	0.000935	0.00327	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—CHRNA4—nicotine dependence	0.000871	0.00304	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000865	0.00302	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.000854	0.00299	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000847	0.00296	CbGpPWpGaD
Disopyramide—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000846	0.00296	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000844	0.00295	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000836	0.00292	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000829	0.0029	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000827	0.00289	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000819	0.00286	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000806	0.00282	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000797	0.00279	CbGpPWpGaD
Disopyramide—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000786	0.00275	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000769	0.00269	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.000766	0.00268	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000759	0.00265	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000744	0.0026	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0007	0.00245	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000698	0.00244	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000691	0.00241	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000664	0.00232	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	0.000662	0.00231	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.000656	0.00229	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.000631	0.00221	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	0.000629	0.0022	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000623	0.00218	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000603	0.00211	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	0.000601	0.0021	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.0006	0.0021	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000598	0.00209	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000595	0.00208	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000592	0.00207	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000457	0.0016	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	0.000455	0.00159	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000454	0.00159	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	0.000453	0.00158	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000451	0.00158	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000448	0.00157	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CYP2A7—nicotine dependence	0.000405	0.00142	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CYP2A7—nicotine dependence	0.000378	0.00132	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000357	0.00125	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FGD1—nicotine dependence	0.000356	0.00125	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	0.000356	0.00124	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FGD1—nicotine dependence	0.000355	0.00124	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000352	0.00123	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.000352	0.00123	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP2A7—nicotine dependence	0.000349	0.00122	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	0.000324	0.00113	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	0.000323	0.00113	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.00032	0.00112	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	0.000315	0.0011	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	0.000314	0.0011	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000311	0.00109	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	0.000258	0.000902	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	0.000257	0.000899	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.000255	0.00089	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	0.000234	0.000819	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	0.000234	0.000816	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000231	0.000808	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—WASF2—nicotine dependence	0.000222	0.000775	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—WASF2—nicotine dependence	0.000221	0.000773	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000219	0.000765	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—WASF1—nicotine dependence	0.000213	0.000743	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—WASF1—nicotine dependence	0.000212	0.000741	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.00021	0.000734	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	0.000191	0.000669	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	0.000191	0.000667	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000189	0.000661	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—DRD2—nicotine dependence	0.000138	0.000484	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—DRD2—nicotine dependence	0.000138	0.000482	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.000137	0.000478	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000136	0.000477	CbGpPWpGaD
